Based on these encouraging results, a randomized controlled, open-label phase II/III study to evaluate the efficacy of IAH0968 combined with chemotherapy as first-line treatment with HER2-positive advanced colorectal cancer is ongoing (Chinadrugtrials.org.cn: NCT05991518). Here, ERBB2 is linked to colorectal cancer.